Lacerta Therapeutics Signs Gene Therapy Research Partnership With UCB
UF startup and UF Innovate | Sid Martin Biotech alum Lacerta Therapeutics, a clinical-stage gene therapy company, announced a new gene therapy... Read More
AGTC Reports Additional Positive Data From Its Phase 1/2 Clinical Trial in Patients With X-Linked Retinitis Pigmentosa
UF startup and UF Innovate | Sid Martin Biotech alum Applied Genetic Technologies Corporation (AGTC), a biotechnology company conducting human clinical trials... Read More
Lacerta Therapeutics Strengthens Its Position in the AAV Gene Therapy Space With New Leadership
UF startup and UF Innovate | Sid Martin Biotech alum Lacerta Therapeutics, a clinical-stage gene therapy company, announced new leadership. Dr. Edgar... Read More
Department of Defense Awards Ology Bioservices Contract to Manufacture and Test Novel Live Attenuated Tularemia Vaccine Candidate
UF startup and UF Innovate | Sid Martin Biotech alum Ology Bioservices Inc., a biologics contract development and manufacturing organization (CDMO), announced... Read More
ABEC Supporting Ology Bioservices COVID-19 Therapeutic Manufacturing Programs
ABEC, a leading global provider of integrated solutions and services for biopharmaceutical manufacturing, announced it is delivering process systems to UF startup... Read More
entrinsic bioscience Secures U.S. Patent Grant for Breakthrough Respiratory Disease Program
UF startup and UF Innovate | Sid Martin Biotech resident client entrinsic bioscience (EBS), a company pioneering a next-generation protein modulation technology,... Read More
Concept Companies Unveils New Office for Lacerta Therapeutics in Alachua’s Copeland Park
Gainesville-based developer Concept Companies has completed construction on a new 12,950-square-foot office and lab building in Copeland Park for UF startup and... Read More
AGTC Joins the My Retina Tracker Program as a New Scientific Collaborator
UF startup and UF Innovate | Sid Martin Biotech alum Applied Genetic Technologies Corporation (AGTC), Blueprint Genetics, and Foundation Fighting Blindness, announced... Read More
TearClear Appoints Robert Bailey to Board of Directors
UF startup and UF Innovate | Sid Martin Biotech resident client TearClear, a global ophthalmic pharmaceutical company, announces the appointment of industry veteran... Read More
Using HSV Helper Viruses to Increase AAV Production
Recognizing the industry-wide need to improve adeno-associated virus (AAV) vector manufacturing, UF startup and UF Innovate | Sid Martin Biotech alum Applied Genetic Technologies Corporation... Read More
